These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. RNP2 of RNA recognition motif 1 plays a central role in the aberrant modification of TDP-43. Takagi S; Iguchi Y; Katsuno M; Ishigaki S; Ikenaka K; Fujioka Y; Honda D; Niwa J; Tanaka F; Watanabe H; Adachi H; Sobue G PLoS One; 2013; 8(6):e66966. PubMed ID: 23840565 [TBL] [Abstract][Full Text] [Related]
11. TDP-43 associates with stalled ribosomes and contributes to cell survival during cellular stress. Higashi S; Kabuta T; Nagai Y; Tsuchiya Y; Akiyama H; Wada K J Neurochem; 2013 Jul; 126(2):288-300. PubMed ID: 23398327 [TBL] [Abstract][Full Text] [Related]
12. Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Seyfried NT; Gozal YM; Dammer EB; Xia Q; Duong DM; Cheng D; Lah JJ; Levey AI; Peng J Mol Cell Proteomics; 2010 Apr; 9(4):705-18. PubMed ID: 20047951 [TBL] [Abstract][Full Text] [Related]
13. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. Miguel L; Frébourg T; Campion D; Lecourtois M Neurobiol Dis; 2011 Feb; 41(2):398-406. PubMed ID: 20951205 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522 [TBL] [Abstract][Full Text] [Related]
15. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. Nishimoto Y; Ito D; Yagi T; Nihei Y; Tsunoda Y; Suzuki N J Biol Chem; 2010 Jan; 285(1):608-19. PubMed ID: 19887443 [TBL] [Abstract][Full Text] [Related]